TRACEY MICHELS: Open Payments
NPI 1811404312 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,790 in 87 payments from 30 companies in 2025. Trend: 2023 $647 · 2024 $1,219 · 2025 $1,790
Food & beverage: $1,790
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $418 |
| Novo Nordisk Inc | 11 | $198 |
| PFIZER INC. | 10 | $138 |
| Neurocrine BioSciences, Inc. | 4 | $96 |
| Exact Sciences Corporation | 4 | $78 |
| ABBVIE INC. | 4 | $74 |
| GlaxoSmithKline, LLC. | 4 | $69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
| Axsome Therapeutics, Inc. | 2 | $46 |
Products named: AIRSUPRA, BREZTRI, INGREZZA, Rybelsus, Cologuard Collection Kit, NURTEC ODT, JARDIANCE, TRELEGY ELLIPTA.
Industry payments across MI — which companies pay providers there.
